MBio funded to work on HIV diagnostic test

BOULDER – MBio Diagnostics Inc. in Boulder has received $1.4 million to develop a device that would quickly diagnose HIV antigen and antibodies.

The award from the Small Business Innovative Research program will continue work for two years based on the results of a Phase I project in which research and development of a point-of-care antigen/antibody combination diagnostic device met or exceeded technical milestones.

MBio’s HIV antigen and antibody assays combined outperform FDA approved rapid tests, and provide near equivalence of much more complicated laboratory-based tests.

MBio has had a longstanding collaboration with a team of infectious-disease experts at the University of California,…